Paralysis
Atorvastatin promotes a Th2 bias, reverses paralysis in CNS autoimmune disease
Published in Pain and Central Nervous System Week, January 6th, 2003
"Atorvastatin (Lipitor) was tested in chronic and relapsing experimental autoimmune encephalomyelitis, a CD4+ Th1-mediated central nervous system (CNS) demyelinating disease model of multiple sclerosis," wrote S. Youssef and colleagues in the journal Nature.
"Atorvastatin induced STAT6 phosphorylation and secretion of Th2 cytokines (interleukin (IL)-4, IL-5, and IL-10) and transforming growth factor (TGF)-beta. Conversely, STAT4 phosphorylation was inhibited and secretion of Th1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- Epilepsy
Increased link found between worsening seizures and women taking estrogen - Neurodegeneration
Tumor suppressor protein capable of igniting neuron differentiation - Cerebral Edema
Hypoxia-induced VEGF expression causes vascular leakage in the brain - Neurochemistry
L-periaxin antibodies in sera of certain patients produce nerve deficits - Neurodegeneration
Botulinum neurotoxin gene transfer partly alleviates cognitive deficits in mice - Parkinson Disease
Study finds link to driving impairment - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
